ELISpot Plus: Human IL-2 (ALP)

Korber, N., et al. (2016). Validation of an IFNgamma/IL2 FluoroSpot assay for clinical trial monitoring. J Transl Med.

Forghieri, F., et al. (2016). Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation. British Journal of Haematology.

Bergström, S.-E., et al. (2015). Antigen-induced regulation of T-cell motility, interaction with antigen-presenting cells and activation through endogenous thrombospondin-1 and its receptors. Immunology.

Zimmermann, K., et al. (2015). Gut commensal microbes do not represent a dominant antigenic source for continuous CD4+T-cell activation during HIV-1 infection. European journal of immunology.

Mazor, R., et al. (2017). Rational design of low immunogenic anti CD25 recombinant immunotoxin for T cell malignancies by elimination of T cell epitopes in PE38. Cellular immunology.